GSK, Moderna settle patent dispute over Moderna COVID, RSV shots

MarketScreener · Reuters · 2026-11-06 18:13 UTC

British drugmaker GSK has settled lawsuits that accused Moderna's COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Friday. o...

Read the full story at MarketScreener · All coverage of this story